MedPath
TGA Approval

PROHANCE gadoteridol 4189.5mg/15mL injection vial (72671)

72671

PROHANCE gadoteridol 4189.5mg/15mL injection vial

Bracco Pty Ltd

September 1, 2000

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/a435de07acef5f77e98bc3cf8934e158.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/3803ab43fdcea007b8636c4a55ffed9f.pdf

Active Ingredients

gadoteridol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROHANCE gadoteridol 4189.5mg/15mL injection vial (72671) - TGA 批准文号 | MedPath